CDC Renews Injury Prevention Board: Yawn, Business as Usual
Published Date: 3/4/2026
Notice
Summary
The CDC just renewed the Board of Scientific Counselors for the National Center for Injury Prevention and Control’s charter for two more years, keeping their important work going through January 13, 2028. This means the board will keep advising on injury prevention strategies that affect public health, with no new costs announced. The renewal ensures the board stays active and ready to tackle injury-related challenges ahead.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Injury Prevention Board Charter Renewed
The CDC renewed the charter for the Board of Scientific Counselors for the National Center for Injury Prevention and Control for a two-year period, keeping the board active through January 13, 2028. The notice states that no new costs were announced with this renewal.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10039 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on a new survey project to make health care data better and easier to collect. If you or your agency deals with health info, now’s the time to share your feedback—there’s a 30-day window to comment. This review aims to cut down paperwork hassle and keep costs in check, so everyone wins!
2026-10012 — Advisory Committee on Immunization Practices (ACIP); Notice of Charter Re-Establishment
The CDC is officially bringing back the Advisory Committee on Immunization Practices (ACIP) for another two years after a paperwork mix-up caused a brief pause. This committee helps guide vaccine decisions that affect everyone’s health, so its return keeps important vaccine advice on track without extra costs or delays. The re-establishment shows the CDC’s commitment to keeping us safe and informed about immunizations.
2026-09770 — Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health
The Advisory Board on Radiation and Worker Health is meeting on June 18, 2026, to discuss important updates about helping workers exposed to radiation get fair compensation. Workers affected by radiation exposure and their families can share written comments by June 11. This meeting helps make sure the rules and science behind compensation stay accurate and fair, with no new costs or delays expected.
2026-09434 — Proposed Data Collection Submitted for Public Comment and Recommendations
The CDC wants your thoughts on their plan to keep collecting important data about infections caught in healthcare settings through the National Healthcare Safety Network (NHSN). This helps hospitals and health officials spot problems and stop infections. If you have ideas or concerns, send them by July 13, 2026—no extra costs or big changes, just smarter tracking!
2026-09436 — Proposed Data Collection Submitted for Public Comment and Recommendations
The CDC wants your thoughts on their plan to keep collecting important data about respiratory illnesses like COVID-19, flu, and RSV to help protect public health. This affects hospitals and health agencies who share this info, and your feedback can shape how the data is gathered. Comments are open until July 13, 2026, with no new costs announced, just a chance to make the process better and easier.
2026-09245 — World Trade Center Health Program; Petitions 032, 033, and 068-Peripheral Neuropathy; Finding of Insufficient Evidence
The World Trade Center Health Program reviewed requests to add peripheral neuropathy as a covered health condition but found not enough proof to do so. This means people affected by 9/11 won’t see changes to their benefits for this condition right now. The decision was made official on May 11, 2026, with no new costs or coverage updates planned.
Previous / Next Documents
Previous: 2026-04236 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Genentech about certain pertuzumab biosimilars being imported and sold in the U.S. They want to stop these products because of patent issues. The Commission is asking the public to share their thoughts on how this might affect everyone, with decisions and possible actions happening soon, including a 60-day review period.
Next: 2026-04238 — Proposed Collection; 60-Day Comment Request; Regular Clearance for the National Institute of Mental Health Data Archive (NDA), (NIMH)
The National Institute of Mental Health (NIMH) wants to keep collecting important mental health data through its Data Archive and is asking the public to share their thoughts by May 4, 2026. This helps make sure the data collection is useful, clear, and not too much work for those involved. No big changes or costs are expected, just a smooth extension to keep the research going strong.